Prostate Cancer Prostatic Dis
Dr. Jianqing Lin, MD
- Medicare services, 2024
- 1,061
- Medicare patients, 2024
- 342
- Part D claims, 2024
- 1,242
- Publications
- 34
- Clinical trials
- 10
- Practice address
- 2010 Health Campus Drive, Harrisonburg, VA 22801
- Practice phone
- Call (540) 689-1000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Lin's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jianqing Lin is a medical oncologist in Rockingham, Virginia
Dr. Lin practices at Sentara RMH Medical Center in Harrisonburg, Virginia, part of Sentara Health.
Dr. Lin's NPI, 1285787267, was assigned on January 21, 2007. Dr. Lin holds Virginia license 0101276780.
- NPI
- 1285787267NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3971658733
- NPI enumeration date
- January 21, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (540) 689-1000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 66
- Medical school graduation
- 1986
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jianqing Lin practices at Sentara RMH Medical Center in Harrisonburg, Virginia
Dr. Lin's primary practice is Sentara RMH Medical Center, at 2010 Health Campus Drive, Harrisonburg, VA 22801 in Harrisonburg City. The practice phone is (540) 689-1000.
- Sentara RMH Medical Center2010 Health Campus Drive, Harrisonburg, VA 22801 · Harrisonburg CityPhone(540) 689-1000
Source: Dmand AI Affiliation Data
Dr. Jianqing Lin is affiliated with 4 sites of care and 1 medical group
Dr. Lin's primary practice is Sentara RMH Medical Center in Harrisonburg, Virginia, part of Sentara Health. Dr. Lin is also affiliated with University Medical Center. The medical group on file is Sentara RMH Medical Group. Dmand AI also links Dr. Lin to 1 more hospital and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Jianqing Lin's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Sentara RMH Medical Center | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Sentara Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jianqing Lin is one of 99 medical oncologists in Virginia
Medical oncology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Lin's licenses on file in 4 states: Virginia, District of Columbia, Maryland and Pennsylvania.
Specialties and state licenses
- Medical oncology, VirginiaPrimary
- District of Columbia license
- Specialist, Maryland
- Pennsylvania license
Medical oncologists near Dr. Lin
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jianqing Lin billed Medicare for 1,061 services in 2024
CMS data shows 1,061 Medicare services from Dr. Lin across 6 procedure codes in 2024, for 342 Medicare patients. Medicare paid $74,557 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Lin's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,0382024: 1,0612%
Dr. Lin compared with the Virginia median for medical oncologists, 2024
- Dr. Lin
- Virginia median
- Medicare services
- 1,061vs 56687% above
- Medicare patients
- 342vs 22254% above
- Part D claims
- 970vs 3033.2 times
Medians across 96 medical oncologists in Virginia with Dmand AI profiles that report each measure.
Dr. Lin's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Lin?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lin and other medical oncologists in Virginia.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Jianqing Lin treated 342 Medicare patients in 2024, average age 75
CMS counts 342 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 67, with 48% women.
Dr. Lin's Medicare patients by age, 2024
Dr. Lin's Medicare patients by sex, 2024
- Women15746%
- Men18554%
Chronic conditions among Dr. Lin's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis49%
- Cancer48%
- Diabetes37%
- Anxiety31%
- Ischemic heart disease30%
- Mood disorders30%
Share of Medicare patients with each condition. A patient can have several.
Dr. Lin's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women48%
- Men52%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Jianqing Lin wrote 1,242 Medicare Part D claims in 2024
In 2024, Dr. Lin wrote 1,242 Medicare Part D claims for 235 patients. 82% of them were for generic drugs. CMS names the drug for 970 of them, across 34 drugs with 11 or more claims each, at $2,000,266 in total drug cost. In 2023, CMS named 744 claims across 28 drugs.
Dr. Lin's Part D claims by kind of drug, 2024
- Generic1,022 claims82%
- Brand-name220 claims18%
Dr. Lin's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Lin's Part D claims, 2024
- Opioids4%50 of 1,242 claims
- Antibiotics4%54 of 1,242 claims
- Antipsychotics, patients 65 and over1%14 of 1,242 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 7442024: 97030%
Drugs named by CMS: 34 in 2024, 28 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Jianqing Lin takes part in Medicare
Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jianqing Lin has 34 publications on record
Dmand AI links 34 papers to Dr. Lin, published from 2010 to 2023. 2016 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant and Antineoplastic Agents. Dr. Lin has published most often in Am J Clin Oncol. Dr. Lin's most frequent co-authors are Adam P. Dicker, MD, Robert B. Den, MD and Jean H. Hoffman-Censits, MD.
Dr. Lin's papers by year, 2011 to 2023
Topics Dr. Lin writes about most
- Prostatic Neoplasms
- Prostatic Neoplasms, Castration-Resistant
- Antineoplastic Agents
- Molecular Targeted Therapy
- Neoplasm Metastasis
- Prostate-Specific Antigen
- Receptors, Androgen
- Androgen Antagonists
Dr. Lin's most frequent co-authors
- Adam P. Dicker, MD6 shared papers
- Robert B. Den, MD5 shared papers
- Jean H. Hoffman-Censits, MD3 shared papers
Recent publications by Dr. Lin
Clin Genitourin Cancer
See who Dr. Lin researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lin works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jianqing Lin has worked on 10 clinical trials
Dmand AI links Dr. Lin to 10 clinical trials, 4 of them phase 1 studies. 7 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Carcinoma, Renal Cell. Sidney Kimmel Cancer Center at Thomas Jefferson University sponsors the most, 5.
Clinical trials with Dr. Lin by phase
- 4Phase 1: 4 trials
- 1Phase 2: 1 trial
- 4Phase 3: 4 trials
- NonePhase 4: no trials
Conditions in Dr. Lin's trials
- Prostatic Neoplasms
- Prostatic Diseases
- Carcinoma, Renal Cell
- Lymphatic Metastasis
- Pancreatic Neoplasms
Investigators on the most trials with Dr. Lin
- Adam P. Dicker, MD4 shared trials
- Robert B. Den, MD3 shared trials
- Jean H. Hoffman-Censits, MD3 shared trials
Recent clinical trials with Dr. Lin
A Randomized Phase ll Study of Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma (opens in a new tab)
CASPAR - a Phase III Trial of Enzalutamide and Rucaparib As a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer (opens in a new tab)
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Jianqing Lin received $15,400 in industry payments from 2016 to 2024
CMS Open Payments shows 76 general payments to Dr. Lin from 16 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 56% of the total. AstraZeneca Pharmaceuticals LP paid the most, $10,085.
General payments to Dr. Lin by program year, 2016 to 2024
General payments to Dr. Lin by kind, 2016 to 2024
- Speaker and faculty fees$8,70056%
- Travel and lodging$3,23021%
- Food and beverage$2,82218%
- Education$6484%
Companies that paid Dr. Lin the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Jianqing Lin's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jianqing Lin
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jianqing Lin's NPI number?
Dr. Jianqing Lin's NPI number is 1285787267. It was assigned on January 21, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Jianqing Lin?
Dr. Jianqing Lin is a medical oncologist in Rockingham, Virginia. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Jianqing Lin practice?
Dr. Lin practices at 2010 Health Campus Drive, Harrisonburg, VA 22801. Dr. Lin's primary practice is Sentara RMH Medical Center in Harrisonburg, Virginia, part of Sentara Health. Dmand AI also links Dr. Lin to 1 hospital and 1 group practice or clinic.
What is Dr. Jianqing Lin's office phone number?
The practice phone on file for Dr. Lin is (540) 689-1000.
What is Dr. Jianqing Lin's medical license number?
Dr. Lin holds Virginia license 0101276780, one of the licenses on file in 4 states.
Which states has Dr. Jianqing Lin been licensed in?
Dmand AI has state licenses on file for Dr. Lin in Virginia, District of Columbia, Maryland and Pennsylvania.
Which hospitals is Dr. Jianqing Lin affiliated with?
Dr. Lin practices at Sentara RMH Medical Center in Harrisonburg, Virginia. Dr. Lin is also affiliated with University Medical Center. Dmand AI links Dr. Lin to 1 more hospital.
What medical group is Dr. Jianqing Lin part of?
Dr. Lin is linked to Sentara RMH Medical Group.
Does Dr. Jianqing Lin accept Medicare?
Yes. CMS data shows Dr. Lin billed Medicare for 1,061 services in 2024, and Dr. Lin accepts Medicare assignment.
How many Medicare patients does Dr. Jianqing Lin see?
CMS counts 342 Medicare patients who saw Dr. Lin in 2024, with an average age of 75.
Show 6 more questionsShow fewer questions
What services does Dr. Jianqing Lin bill to Medicare?
In 2024, Dr. Lin's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, established patient (99215).
What drugs does Dr. Jianqing Lin prescribe most?
In 2024 Medicare Part D data, Dr. Lin's most prescribed drugs by claims were Anastrozole, Levothyroxine Sodium and Prochlorperazine Maleate.
Has Dr. Jianqing Lin received payments from drug or device companies?
CMS Open Payments shows $15,400 in general payments to Dr. Lin from 16 companies from 2016 to 2024. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Jianqing Lin been practicing?
Dr. Lin graduated from medical school in 1986, 40 years ago.
Does Dr. Jianqing Lin do research?
Dmand AI links 34 publications to Dr. Lin, published from 2010 to 2023. Dr. Lin has worked on 10 clinical trials.
Who does Dr. Jianqing Lin publish with?
Dr. Lin's most frequent co-authors are Adam P. Dicker, MD (6 shared papers), Robert B. Den, MD (5 shared papers) and Jean H. Hoffman-Censits, MD (3 shared papers).
Selling to medical oncology practices?
See medical oncologists in Virginia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card